From: Risk factors for venous port migration in a single institute in Taiwan
All patients | Bard port | TYCO port | P value | ||||
---|---|---|---|---|---|---|---|
n | % | n | % | n | % | ||
Patient number | 298 | 104 | 194 | ||||
Age | 0.0116 | ||||||
mean ± standard deviation | 61.4 ± 12.3 | 63.9 ± 11.3 | 60.1 ± 12.7 | ||||
median (inter-quartile range) | 61 (54 to 70.8) | 63.1 (56.3 to 72) | 60 (51 to 69) | ||||
Sex | 0.0034 | ||||||
Female | 153 | 51.3% | 41 | 39.4% | 112 | 57.7% | |
Male | 145 | 48.7% | 63 | 60.6% | 82 | 42.3% | |
Body mass index | 0.1077 | ||||||
mean ± standard deviation | 24.2 ± 6.8 | 23.4 ± 3.6 | 24.7 ± 8.0 | ||||
medium (inter-quartile range) | 23.6 (21.1 to 26.4) | 23.4 (21.1 to 25.4) | 23.9 (21.0 to 26.7) | ||||
Migration | 0.0006 | ||||||
No | 291 | 97.7% | 97 | 93.3% | 194 | 100.0% | |
Yes | 7 | 2.3% | 7 | 6.7% | 0 | 0.0% | |
Side | < 0.0001 | ||||||
Left | 97 | 32.6% | 19 | 18.3% | 78 | 40.2% | |
Right | 201 | 67.5% | 85 | 81.7% | 116 | 59.8% | |
Entering vessel | < 0.0001 | ||||||
Cephalic vein | 261 | 87.6% | 102 | 98.1% | 159 | 82.0% | |
Subclavian vein | 37 | 12.4% | 2 | 1.9% | 35 | 18.0% | |
Malignancy (indication for the port) | |||||||
Head and neck tumor | 17 | 5.7% | 4 | 3.9% | 13 | 6.7% | |
Lung cancer | 59 | 19.8% | 32 | 30.8% | 27 | 13.9% | |
Esophageal cancer | 2 | 0.7% | 0 | 0.0% | 2 | 1.0% | |
Breast cancer | 55 | 18.5% | 4 | 3.9% | 51 | 26.3% | |
Gastric cancer | 14 | 4.7% | 7 | 6.7% | 7 | 3.6% | |
Colorectal cancer | 64 | 21.5% | 29 | 27.9% | 35 | 18.0% | |
Hepatobiliary and pancreatic tumor | 8 | 2.7% | 3 | 2.9% | 5 | 2.6% | |
Ovary cancer and cervical cancer | 26 | 8.7% | 7 | 6.7% | 19 | 9.8% | |
Urological cancer | 37 | 12.4% | 12 | 11.5% | 25 | 12.9% | |
Leukemia and lymphoma | 11 | 3.7% | 3 | 2.9% | 8 | 4.1% | |
Other malignancy | 3 | 1.0% | 1 | 1.0% | 2 | 1.0% | |
Malnutrition, no malignancy | 2 | 0.7% | 2 | 1.9% | 0 | 0.0% | |
Lung cancer | 0.0007 | ||||||
Yes | 59 | 19.8% | 32 | 30.8% | 27 | 13.9% | |
No | 239 | 80.2% | 72 | 69.2% | 167 | 86.1% |